JP2024542777A5 - - Google Patents
Info
- Publication number
- JP2024542777A5 JP2024542777A5 JP2024532973A JP2024532973A JP2024542777A5 JP 2024542777 A5 JP2024542777 A5 JP 2024542777A5 JP 2024532973 A JP2024532973 A JP 2024532973A JP 2024532973 A JP2024532973 A JP 2024532973A JP 2024542777 A5 JP2024542777 A5 JP 2024542777A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- seq
- amino acid
- acid sequence
- sequence shown
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163285513P | 2021-12-03 | 2021-12-03 | |
| US63/285,513 | 2021-12-03 | ||
| EPPCT/EP2021/086689 | 2021-12-20 | ||
| PCT/EP2021/086689 WO2022136209A1 (en) | 2020-12-22 | 2021-12-20 | Interleukin 5 binding protein dosage regimen |
| US202263349622P | 2022-06-07 | 2022-06-07 | |
| US63/349,622 | 2022-06-07 | ||
| PCT/EP2022/084075 WO2023099668A1 (en) | 2021-12-03 | 2022-12-01 | Interleukin 5 binding protein dosage regimen for use in treating polyangiitis, hypereosinophilic syndrome, hypereosinophilic syndrome chronic rhinosinusitis with nasal polyps (crswnp), or chronic rhinosinusitis without nasal polyps (crssnp) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024542777A JP2024542777A (ja) | 2024-11-15 |
| JP2024542777A5 true JP2024542777A5 (https=) | 2025-12-08 |
Family
ID=84688427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024532973A Pending JP2024542777A (ja) | 2021-12-03 | 2022-12-01 | 多発血管炎、好酸球増多症候群、好酸球増多症候群、鼻ポリープを伴う慢性副鼻腔炎（ｃｒｓｗｎｐ）又は鼻ポリープを伴わない慢性副鼻腔炎（ｃｒｓｓｎｐ）の処置における使用のためのインターロイキン５結合タンパク質投与レジメン |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250042985A1 (https=) |
| EP (1) | EP4440617A1 (https=) |
| JP (1) | JP2024542777A (https=) |
| CA (1) | CA3239667A1 (https=) |
| WO (1) | WO2023099668A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026047072A1 (en) * | 2024-08-30 | 2026-03-05 | Glaxosmithkline Intellectual Property Development Limited | Medical use |
| WO2026078117A1 (en) * | 2024-10-11 | 2026-04-16 | Glaxosmithkline Intellectual Property Development Limited | Anti-il-5 antibody in the treatment of chronic rhinosinusitis with nasal polyps |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117018188A (zh) | 2017-05-26 | 2023-11-10 | 葛兰素史密斯克莱知识产权发展有限公司 | 生物制药组合物和相关方法 |
-
2022
- 2022-12-01 CA CA3239667A patent/CA3239667A1/en active Pending
- 2022-12-01 JP JP2024532973A patent/JP2024542777A/ja active Pending
- 2022-12-01 WO PCT/EP2022/084075 patent/WO2023099668A1/en not_active Ceased
- 2022-12-01 US US18/715,320 patent/US20250042985A1/en active Pending
- 2022-12-01 EP EP22830693.2A patent/EP4440617A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025169389A5 (https=) | ||
| RU2006120950A (ru) | Антитело к cd40: препарат и способы | |
| KR20060123483A (ko) | 허혈성 병변의 치료 및 예방을 위한 트레프로스티닐의 용도 | |
| JP2022532927A5 (https=) | ||
| JP2024542777A5 (https=) | ||
| JP2019521156A5 (https=) | ||
| JP2022518944A5 (https=) | ||
| JP2021532176A5 (https=) | ||
| JP2024531314A (ja) | 小児ｍｓを治療するためのオファツムマブ | |
| WO2011097148A3 (en) | Use of oral heparin preparations to treat urinary tract diseases and conditions | |
| Co et al. | Serial office-based intralesional injection of cidofovir in adult-onset recurrent respiratory papillomatosis | |
| JP2022514561A5 (https=) | ||
| EP2138513A1 (en) | Pharmaceutical compositions of antibodies for diseases caused by viruses | |
| JP2024539148A5 (https=) | ||
| JP2024543885A5 (https=) | ||
| JP2021523096A5 (https=) | ||
| JP2024500912A5 (https=) | ||
| KR100302994B1 (ko) | 약독화된비면역원성폭스바이러스또는파라폭스바이러스로부터멀티포텐트파라폭스면역유발인자의약제로서이용하는새로운적용 | |
| CN108883168A (zh) | 使用疫苗治疗癌症或皮肤病变的方法和组合物 | |
| JP2022543956A (ja) | 安定なアルブビルチド組成物 | |
| JP2022526493A5 (https=) | ||
| RU2019108441A (ru) | Режим дозирования | |
| US20230159630A1 (en) | Pan-elr+ cxc chemokine antibodies for the treatment of respiratory disease | |
| CN108014337B (zh) | 一种用于治疗眼自身免疫性葡萄膜炎的药物组合物 | |
| US20230277650A1 (en) | Use of a birnavirus for the treatment of a disease caused by varicella zoster virus (vzv) |